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<ABS>Although the U.S. Department of Veterans Affairs (VA) has prioritized care for posttraumatic 
stress disorder (PTSD), many patients with PTSD remain symptomatic. Patterns of PTSD symptom 
change are not well understood. Thus, the current study was designed to categorize and investigate 
potential predictors of symptom trajectories in patients with PTSD. The sample comprised 2,237 VA 
patients who were diagnosed with PTSD in 2013 and completed at least 4 PTSD Checklist (PCL) 
assessments over 12 weeks. Latent trajectory analysis was used to identify latent classes of patients 
based on PCL scores. Based on model fit indices, 3 trajectories were identified. Compared to patients 
in the mild-improving trajectory (21.9&percnt;), those in the severe-stable trajectory (34.3&percnt;) 
were more likely to be male, relative risk ratio (RRR) &equals; 1.48, 95&percnt; confidence interval 
(CI) [1.08, 2.02]; non-White, RRR &equals; 1.77, 95&percnt; CI [1.33, 2.35]; Hispanic, RRR 
&equals; 2.07, 95&percnt; CI [1.40, 3.04]; and have comorbid depression, RRR &equals; 1.58, 
95&percnt; CI [1.25, 1.99]. Compared to patients in the moderate-improving trajectory 
(43.8&percnt;), those in the severe-stable trajectory were more likely to have sleep disorders, RRR 
&equals; 1.25, 95&percnt; CI [1.01, 1.55]. Our findings suggest that male veterans, minority veterans, 
and veterans with certain comorbid conditions may be less likely to achieve improved PTSD 
symptoms. Targeted efforts are needed to improve outcomes for PTSD patients on nonremitting 
trajectories and to improve the consistency of PTSD assessment across the VA health care 
system.</ABS>  
 
<P>Posttraumatic stress disorder (PTSD) is a debilitating disorder that currently affects 
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Affairs (VA; U.S. Department of Veterans Affairs, 2012). The number of veterans seeking care for 
PTSD from the VA is steadily increasing (VA, 2012); accordingly, the annual cost of specialized 
PTSD care has risen to over $250 million (VA, 2012). Due to the high prevalence and costly nature of 
PTSD, optimizing care for this disorder is a priority for the VA.</P>  
<P>Although several evidence-based treatments for PTSD have demonstrated efficacy in 
veteran populations (U.S. Department of Veterans Affairs and U.S. Department of Defense, 2010), 
estimates suggest that fewer than 10&percnt; of veterans receive a minimally adequate amount of any 
psychotherapy (Mott, Hundt, Sansgiry, Mignogna, &amp; Cully, 2014). Furthermore, 30 to 
50&percnt; of veterans with PTSD who engage in trauma-focused treatment fail to respond 
adequately (Steenkamp, Litz, Hoge, &amp; Marmar, 2015). Data from trauma survivors suggest that 
individuals with similar initial severity levels may have heterogeneous responses to treatment, and 
that latent symptom classes may be better predictors of treatment response than baseline symptoms 
(Galatzer-Levy et al., 2013). Currently, however, patterns of symptom change for veterans with PTSD 
across the VA are not well understood, nor are the factors that predict these patterns (Schneider, Arch, 
&amp; Wolitzky-Taylor, 2015). Previous studies suggest that potential predictors of persistent 
symptoms include higher pretreatment PTSD severity (Elliott, Biddle, Hawthorne, Forbes, &amp; 
Creamer, 2005; Taylor, 2004; van Minnen, Arntz, &amp; Keijsers, 2002), male gender (Hamner, 
Robert, &amp; Frueh, 2004), minority race/ethnicity (Schumm, Walter, &amp; Chard, 2013; Walter, 
Varkovitzky, Owens, Lewis, &amp; Chard, 2014), younger age (Elliott et al., 2005), comorbid 
depression (Galatzer-Levy et al., 2013; Stein, Dickstein, Schuster, Litz, &amp; Resick, 2012), other 
psychiatric (Feeny, Zoellner, &amp; Foa, 2002; Tarrier, Sommerfield, Pilgrim, &amp; Faragher, 
2000) and medical (Currier, Holland, &amp; Drescher, 2014; Iosifescu et al., 2003) comorbidities, as 
well as delays in treatment initiation (Macdonald, Monson, Doron-Lamarca, Resick, &amp; Palfai, 
2011). Whereas the majority of these studies are based on secondary analyses of randomized trials, a 
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Minnen et al., 2002; Walter et al., 2014), and one examined outcomes across several inpatient PTSD 
programs in Australia (Elliott et al., 2005). Findings from randomized treatment trials may not map 
onto the complex population of patients with comorbid conditions receiving care for PTSD at the VA. 
Furthermore, single-site studies and residential treatment studies may not generalize across the 
broader health care system. Thus, the current study was designed to categorize patterns of PTSD 
symptom change in a national sample across VA facilities and to investigate potential predictors of 
those symptom trajectories. Moreover, this study capitalized on VA data systems to capture “real 
world” outcomes. Better characterization of symptom trajectories may enable providers to improve 
the symptom outcomes and functioning of veterans with a high burden of illness and may help to 
identify those who need additional services. Based on previous reports, we hypothesized that 
racial/ethnic minority veterans, male veterans, and veterans with a higher burden of comorbidity 
would be more likely to experience less-favorable symptom trajectories.</P> 
<H1>Method</H1> 
<H2>Data Source</H2> 
<P>The VA Corporate Data Warehouse provided data on patient demographic characteristics, 
mental health symptoms, and diagnoses. The Veterans Affairs Ann Arbor Healthcare System 
Institutional Review Board approved this study and granted a waiver of informed consent for access 
to protected health information.</P>  
<H2>Participants</H2> 
<P>The sample consisted of 2,237 patients who received a new PTSD diagnosis in fiscal year 
2013 (after at least 180 days without a diagnosis of PTSD) and completed at least four (and up to six) 
PTSD Checklist assessments (PCL; Weathers, Huska, &amp; Keane, 1991) over 12 weeks. The first 
PCL was required to be completed within 1 year of initial diagnosis. Each patient contributed to the 
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was chosen to capture the typical weekly or biweekly frequency at which psychotherapy is delivered, 
given that the PCL is most often administered during the course of mental health treatment (Maguen 
et al., 2014). For patients who completed more than one PCL per 14-day window, only the first PCL 
for that 14-day window was included. To identify new episodes of care, the analysis only included 
patients who had a 180-day dormant period without a diagnosis of PTSD prior to their index 
diagnosis. We also limited our analysis to the 41 (out of 141) facilities where at least 5&percnt; of 
PTSD-diagnosed patients met the above criteria for regular assessment (at least four PCLs in 12 
weeks).</P>  
<H2>Outcome Measure</H2>  
<P>PTSD symptoms were measured using the PCL (Weathers et al., 1991), a 17-item self-report 
measure of PTSD symptoms based on criteria according to the Diagnostic and Statistical Manual of 
Mental Disorders (4th ed., DSM-IV; American Psychiatric Association, 1994). Scores range from 17 
to 85. A score of 50 or above has often been used to indicate a high probability of a clinical diagnosis 
of PTSD (Weathers, Litz, Herman, Huska, &amp; Keane, 1993). Scores were included from the PCL-
civilian, the PCL-military, and the PCL-specific versions. The PCL has excellent psychometric 
properties, including high internal consistency, good test–retest reliability, and strong convergent and 
divergent validity (Blanchard, Jones-Alexander, Buckley, &amp; Forneris, 1996; Ruggiero, Del Ben, 
Scotti, &amp; Rabalais, 2003). Since 2010, PCL administration has been mandated upon initial 
contact with patients who have a PTSD diagnosis and are seeking mental health treatment (Harpaz-
Rotem, Tsai, Pietrzak, &amp; Hoff, 2014).</P> 
<H2>Demographic Characteristics and Measures of Service Utilization</H2>  
<P>Measures of demographic characteristics included sex, age (&lt; 35, 35&ndash;64, &ge; 
65 years), race (White, non-White, unknown/missing), ethnicity (Hispanic/Latino, non-




This article is protected by copyright. All rights reserved. 
 
mental health encounters in the past year (denoted by standardized codes in the electronic medical 
record), the time from initial PTSD diagnosis until first PCL administration, and the number of 
psychotherapy visits during the 12-week trajectory period. We also calculated average initial and final 
scores for each trajectory.</P> 
<H2>Psychiatric and Medical Comorbidities</H2> 
<P>Past-year psychiatric comorbidities were identified using International Classification of 
Diseases, 9th Edition, Clinical Management (ICD-9-CM<zaq;2>) data in primary or secondary 
positions from inpatient and ambulatory care visits for the following disorders: unipolar depressive 
disorders, bipolar or psychotic disorders, alcohol or substance use disorders, and other anxiety 
disorders. The medical comorbidities of interest included sleep disorders and traumatic brain injury. 
We also calculated each individual’s Elixhauser comorbidity score, an index that classifies 
comorbidity according to severity (van Walraven, Austin, Jennings, Quan, &amp; Forster, 2009). 
Following Zivin and colleagues (2013), due the high rate of comorbidity between PTSD and 
depression, we excluded from the Elixhauser calculation all ICD-9 codes associated with depression 
(300.4, 301.12, 309.0, 309.1, and 311).</P>  
<H2>Data Analysis</H2> 
<P>Analyses were conducted in two phases. First, latent trajectory analysis was used to 
identify latent groups of patients based on their PCL scores over the course of the 12 weeks following 
initial assessment. Latent trajectory analysis is a method that identifies clusters of individuals 
following a similar progression of an outcome over time (Nagin &amp; Odgers, 2010). This method 
assumes that the population is composed of a finite mixture of distinct groups defined by their 
developmental trajectories (Nagin &amp; Odgers, 2010). Analyses were conducted using PROC 
TRAJ in SAS version 9.2 (SAS Institute, 2009<zaq;3>) using maximum likelihood estimation. The 
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in weeks. A censored normal (CNORM) distribution was used to fit the continuous data provided by 
the PCL scores. Both linear and quadratic terms were estimated during model fitting, following Nagin 
(2005), and up to six classes were specified. Fit indices, entropy (average posterior probability), 
interpretability of classes, and comparability to prior studies were used to determine the number of 
trajectories in the final model. Invariance testing was used to compare the slopes of the trajectories. 
Patients were assigned to the trajectory to which they had the highest posterior probability of 
membership.</P> 
<P>Second, bivariate analyses (Wilcoxon-Mann-Whitney and &khgr;<SUP>2</SUP> tests) 
were used to examine the relationship between trajectory membership and demographic 
characteristics, psychiatric comorbidities, and medical comorbidities. There were 15 individuals in the 
final sample who were missing data on marital status. No other variables were missing. Multinomial 
logistic regression was then used to model relationships between the covariates that were significant 
in bivariate analyses and the group membership variable. For the primary analysis, the least severe 
symptom trajectory was used as the reference group. Relative risk ratios (RRRs) with 95&percnt; 
confidence intervals (CIs) were used to compare covariates between the groups.</P>  
<H1>Results</H1> 
<P>The final sample consisted of 10,505 PCL measurements from 2,237 patients (see Figure 
1{FIG1} for a flow diagram of sample selection). These patients were drawn from 41 facilities 
meeting our criteria of regular assessment for at least 5&percnt; of patients (mean compliance 
&equals; 9.2&percnt;; range &equals; 5.0&percnt; to 23.1&percnt;). The remaining 100 facilities 
(treating 265,516 patients) were excluded from the analysis because fewer than 5&percnt; of patients 
at these facilities received regular assessments. Demographic characteristics of the final sample and of 
the broader population of PTSD-diagnosed patients are presented in Table 1{TBL 1}. Compared to 
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non-White and Hispanic and to have comorbid anxiety or a comorbid sleep disorder. They were less 
likely to be over the age of 65, male, or have comorbid bipolar disorder. They had slightly less 
medical comorbidity and more mental health visits in the past year. The goodness-of-fit indices for 
the 1- to 6-group models are presented in Table 2{TBL 2}. Based on fit indices, parsimony, 
interpretability of classes, and comparability to prior studies, a 3-group model was judged to be the 
optimal solution. Although model fit statistics were marginally superior for the 4-group model as 
compared to the 3-group model, the 3-group model exhibited higher entropy, was most interpretable, 
and provided the best comparison to previous studies. Furthermore, a visual inspection of the models 
with larger numbers of groups suggested that these models did not provide additional trajectories that 
were qualitatively different from those of the 3-group model. The three trajectories of patients were 
classified as follows: mild-improving (Group 1; comprising 21.8&percnt; of the sample), moderate-
improving (Group 2; 43.8&percnt;), and severe-stable (Group 3; 34.3&percnt;; see Figure 2{FIG2}). 
The final model included linear and quadratic effects (see Supplementary Table 1). The slope of the 
mild-improving trajectory (Group 1) was significantly greater than the slope of the moderate-
improving trajectory (Group 2), which in turn was significantly greater than the slope of the severe-
stable trajectory (Group 3; all p &lt; .001). The average posterior probability was .94 for patients 
assigned to Group 1, .92 for patients assigned to Group 2, and .94 for patients assigned to Group 
3.</P> 
<H2>Bivariate Results</H2> 
<P>Bivariate results are presented in Table 3{TBL 3}. There was a significant difference by 
age group such that patients aged 35&ndash;64 were more likely to be members of the severe-stable 
trajectory. Race and ethnicity also varied by group; namely, non-White and Hispanic/Latino patients 
were more likely to be in the severe-stable trajectory. Patients with comorbid depression or comorbid 
sleep disorders were more likely to be in the severe-stable trajectory. The time from initial diagnosis 
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the PCL score change; the average PCL score decreased by 16.23 points in the mild-improving 
trajectory, 8.35 points in the moderate-improving trajectory, and 2.06 points in the severe-stable 
trajectory. There were 61&percnt; of patients (81.9&percnt; of the mild-improving trajectory, 
66.8&percnt; of the moderate-improving trajectory, and 40.4&percnt; of the severe-stable trajectory) 
who exhibited a PCL score reduction of 10 points or more from the first assessment to the last 
assessment (not shown in the table).</P> 
<H2>Multinomial Regression Results</H2> 
<P>Results that were significant in the adjusted multinomial regression model are presented 
in Table 4{TBL 4}. Compared to patients in the mild-improving trajectory (Group 1), those in the 
severe-stable trajectory (Group 3) were more likely to be male. Patients in the moderate-improving 
(Group 2) and severe-stable (Group 3) trajectories were more likely to be non-White, Hispanic, and 
have comorbid depression. As a supplementary analysis, we changed the reference group to be the 
moderate-improving trajectory so that we could directly compare the severe-stable group to the 
moderate-improving trajectory. Compared to patients in the moderate-improving trajectory, patients 
in the severe-stable trajectory were more likely to have a sleep disorder.</P> 
<H1>Discussion</H1> 
<P>We analyzed trajectories of PTSD symptom change among 2,237 VA patients with a new 
PTSD diagnosis in fiscal year 2013. Based on model fit indices, three distinct symptom trajectories 
were identified: mild-improving (21.9&percnt;), moderate-improving (43.8&percnt;), and severe-
stable (34.3&percnt;). These results are consistent with four previous investigations, all of which have 
identified three trajectories of PTSD symptoms over time (Currier et al., 2014; Elliott et al., 2005; 
Galatzer-Levy et al., 2013; Schumm et al., 2013). Predictors of membership in the severe-stable 
trajectory as compared to the mild-improving trajectory included male gender, non-White race, 
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different patterns of symptom change and that these patterns may be predicted by sociodemographic 
characteristics. However, the extremely small percentage of VA patients who had adequate data for 
this analysis (0.6&percnt; of VA patients with a new PTSD diagnosis in 2013) suggests that more 
regular assessments in the VA are needed. A move toward measurement-based care may help improve 
individual treatment delivery and quality measurement efforts across the system (Trivedi et al., 
2004).</P> 
<P>Our first notable finding was that greater severity at the initial visit was associated with 
greater severity at the final visit. Previous research suggests that higher pretreatment PTSD severity is 
associated with higher posttreatment severity (Currier et al., 2014; Elliott et al., 2005; Hamner et al., 
2004; Taylor, 2004; van Minnen et al., 2002). In this dataset, 61&percnt; of the patients (81.9&percnt; 
of the mild-improving trajectory; 66.8&percnt; of the moderate-improving trajectory; and 
40.4&percnt; of the severe-stable trajectory) exhibited clinically significant reductions in PTSD 
symptoms, as defined by a PCL score reduction of at least 10 points (see Monson et al., 2008). 
Targeted efforts are needed to improve outcomes for the patients who do not experience such 
improvement. Although the number of mental health visits during the 12-week trajectory period was 
not associated with trajectory membership, the overall low number of average psychotherapy sessions 
received (M &equals; five visits) suggests that greater efforts are needed to provide minimally 
adequate doses of psychotherapy to VA patients with PTSD.</P> 
<P>In our sample, male patients were more likely to be on the severe-stable trajectory than on 
the mild-improving trajectory. Previous findings suggest that men experience less improvement than 
do women over the course of residential PTSD treatment (Walter et al., 2014). Furthermore, a 
nationwide study of all veterans of the U.S. military conflicts in Iraq and Afghanistan with a PTSD 
diagnosis treated in the VA system from 2007&ndash;2011 found that male patients were less likely 
than female patients to be remitted one year after the PTSD diagnosis (Maguen et al., 2014). 
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Primary Care PTSD Screen (Prins et al., 2003), which may have lower sensitivity to change. Our 
results extend these findings by demonstrating that, across eras and over the course of four 
assessments, male gender predicted less reduction in PTSD symptoms. Female service members 
experience greater rates of military sexual trauma than male service members (Barth et al., 2016); 
thus, trauma type and subsequently the degree of PTSD symptoms may vary by gender. Further 
research is needed to determine whether male VA patients respond differently to PTSD treatment than 
female VA patients.</P>  
<P>In addition to gender differences, we also found that Hispanic and non-White veterans 
were more likely to be in the moderate-improving and severe-stable trajectories than on the mild-
improving trajectory. Recent reports indicate that African American and Latino veterans are less 
likely to receive a minimal trial of pharmacotherapy for PTSD in the VA system (Spoont et al., 2015). 
Furthermore, African American veterans are less likely to receive a minimal trial of any PTSD 
treatment, even after controlling for factors related to access (Spoont et al., 2015). In terms of 
treatment response, one study demonstrated that Black veterans of the military conflicts in Iraq and 
Afghanistan were less likely to remit over the course of one year (Maguen et al., 2014), and two 
studies found that non-White ethnicity predicted poorer response to cognitive processing therapy 
(CPT; Schumm et al., 2013; Walter et al., 2014). Similar to the current study, Schumm and colleagues 
(2013) found that non-White veterans were more likely to be in a severe symptom trajectory than a 
mild symptom trajectory over time. However, another study found that CPT effects did not differ by 
race (Alvarez et al., 2011), and one study reported that African American veterans undergoing 
prolonged exposure therapy demonstrated a greater improvement of PTSD symptoms than veterans of 
other races (Jeffreys et al., 2014). Therefore, further research is needed to determine ways to improve 
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<P>In terms of psychiatric comorbidity, we found that the presence of comorbid depression 
predicted membership in the severe-stable trajectory. Depression symptoms predicted membership in 
the moderate or severe trajectories as compared to the mild trajectory in four previous latent growth 
models of PTSD symptoms (Elliott et al., 2005; Galatzer-Levy et al., 2013; Schumm et al., 2013; 
Stein et al., 2012). However, the association between higher PCL score and greater illness burden may 
reflect a measurement issue; namely, that the PCL is tapping into generalized distress rather than 
specific aspects of PTSD (Arbisi et al., 2012). Using a combination of standardized assessment 
instruments may provide more insight into the association between comorbid depression and the 
course of PTSD.</P> 
 <P>Finally, we found that comorbid sleep disorders were associated with membership in the 
severe-stable trajectory as compared to the moderate-improving trajectory. This finding is consistent 
with growing evidence that PTSD and sleep disorders exhibit significant overlap and may exacerbate 
each other. For example, veterans with PTSD and obstructive sleep apnea report worse quality of life 
than those with PTSD alone (Lettieri, Williams, &amp; Collen, 2016) and in veterans with TBI and 
PTSD, the presence of insomnia is associated with greater PTSD severity (Lang, Veazey-Morris, 
&amp; Andrasik, 2014). In a study of 659 soldiers returning from deployment in Iraq, greater 
insomnia at 4 months postdeployment was a significant predictor of increased PTSD symptoms at 12 
months postdeployment (Wright et al., 2011). Furthermore, accumulating evidence suggests that poor 
sleep may reduce the efficacy of evidence-based psychotherapy for PTSD (Gilbert, Kark, Gehrman, 
&amp; Bogdanova, 2015). Conversely, treating obstructive sleep apnea with medical interventions 
(such as continuous positive airway pressure) reduces symptoms of PTSD (Krakow et al., 2000; 
Tamanna, Parker, Lyons, &amp; Ullah, 2014). Thus, sleep disorders are an important area of 
assessment for veterans receiving PTSD treatment and may be associated with PTSD treatment 
response as well as PTSD severity. No other clinical variables in our sample were associated with 
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and PTSD treatment response, although one study reported that baseline alcohol use was associated 
with poorer response to inpatient PTSD treatment (Elliott et al., 2005). Further work in broad, 
naturalistic samples is needed to better understand how psychiatric comorbidity may influence PTSD 
treatment response.</P> 
<P>Our findings should be interpreted within the context of several limitations. First, we only 
included individuals who received regular PCL assessments, and we further limited our analysis to 
individuals at the 41 facilities where at least 5&percnt; of PTSD-diagnosed patients received regular 
assessment. These 41 facilities treated 32.4&percnt; of VA patients with a PTSD diagnosis in 2013. 
Our final sample consisted of 0.6&percnt; of VA patients who received a new PTSD diagnosis in 
2013. Thus, our results represent only a very small portion of individuals with PTSD seen by the VA. 
Our analyses resulted in findings that were more representative of the patients at the selected 
facilities. Nonetheless, patients in the final sample differed slightly from the overall PTSD patient 
population with respect to sociodemographic characteristics of interest; thus, the exact percentage of 
patients in each trajectory should be interpreted with caution. Second, we were unable to account for 
potential clustering by facility in this study. Future research may benefit by incorporation of facility 
and facility-level information in analyses. Third, by assigning patients to their most likely class, the 
uncertainty of classification was not accounted for. Fourth, our sample was not necessarily treatment 
seeking; thus, we were unable to determine whether the modeled trajectories represented a response to 
treatment or rather the naturalistic course of the disorder.  Many patients are not actively engaged in 
mental health treatment at any given time; hence, some participants might not have been engaged in 
treatment during the 12-week assessment window. Unfortunately, given the nature of administrative 
data, we were unable to determine the type of psychotherapy received by different groups. Future 
work might use natural language processing of progress note text to specifically identify 
psychotherapy types as potential predictors of response. Nonetheless, all patients in the sample were 
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treatment for PTSD. Although the availability of evidence-based treatment is mandated, recent work 
has shown that a majority of the psychotherapy provided for PTSD in the VA is not evidence-based 
treatment (Finley et al., 2015; Shiner et al., 2013). For example, a recent national survey of 128 PTSD 
clinic therapists revealed that the therapists provided significantly more supportive care than 
evidence-based treatment (Finley et al., 2015). Future work using data captured by the new prolonged 
exposure therapy and CPT templates available in the electronic health record will enable a more 
accurate assessment of whether treatment is evidence-based.</P>  
<P>In conclusion, this is the first national study to examine trajectories of PTSD symptoms 
among those receiving VA services, and we identified three distinct patterns of symptom change in 
VA patients with PTSD over the course of 12 weeks. The severe-stable trajectory included a greater 
proportion of minority veterans and veterans with comorbid depression and sleep disorders. The 
exploration of the biopsychosocial factors associated with PTSD symptom trajectories could identify 
novel predictors compared to traditional methods that consider treatment response as a dichotomous 
outcome or as occurring at a discrete time point.  Moreover, identifying predictors of trajectory 
membership will allow the future construction of classification models to help predict treatment 
response from preexisting variables. However, the small percentage of veterans with available data 
underscores the need for the systematic collection of PTSD symptom measures. Reliable assessment 
will help improve the monitoring of outcomes on a national scale and improve the quality of care that 
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{FIG2}<LEG>Figure 2. Latent trajectories of PTSD Checklist scores over time in outpatients with 
posttraumatic stress disorder (n &equals; 2,237) receiving Veterans Affairs health care services. 
Dashed lines represent trajectories based on estimated means. Solid lines represent trajectories based 
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Table 1. Characteristics of All VA Patients With a PTSD Diagnosis in 2013 and in the Final 
Sample 
 All VA patients 
with PTSD (n = 
390,457) 
Final sample 
(n = 2,237) 
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Age     360.14*** 
 < 35 years 82,042 21.0 720 32.2  
 35–64 years 186,205 47.7 1,202 53.7  
 65+ years 122,210 31.3 315 14.1  
Male gender 355,535 91.1 1,851 82.7 187.29*** 
Race      17.24*** 
 Non-White 92,741 23.8 615 27.5  
 Unknown 29,966 7.7 166 7.4  
Hispanic/Latino 
ethnicity 
28,083 7.2 265 11.9 71.95*** 
Married 210,376 53.9 1,196 53.5 4.57 
Comorbid 
depression  













80,831 20.7 788 35.2 285.07*** 
Comorbid 
sleep disorder  
88,885 22.8 568 25.4 8.74** 
Traumatic 
brain injury  





0.89 5.11 0.12 3.79 8.99*** 
Total mental 
health visits in 
past year 
4.03 10.37 6.09 13.01 15.33*** 
<TFN>Note. VA = U.S. Department of Veterans Affairs; PTSD = posttraumatic stress disorder. *p < .05. **p < .01. ***p < 
.001 
Table 2. Trajectory Fit Statistics 
Number of 
trajectories 
BIC SSBIC AIC L Entropy 
1 42455.55 42452.46 42441.03 42437.03 1.00 
2 39910.38 39904.2 39881.34 39873.34 .96 
3 38984.31 38975.03 38940.75 38928.75 .93 
4 38635.96 38623.59 38577.89 38561.89 .90 
5 38517.84 38502.37 38445.24 38425.24 .86 
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Note.  AIC = Akaike information criterion; BIC = Bayesian information criterion;  
SSBIC = sample size adjusted Bayesian information criterion; L = likelihood ratio. 
Table 3. Patient Characteristics by Trajectory Membership 











    







Age       17.03** 
 < 35 years 167 34.3 323 32.7 230 30.1  
 35–64 years 233 47.8 523 53.0 446 58.5  
 65+ years 87 17.9 141 14.3 87 11.4  
Male Gender 397 81.5 811 82.2 643 84.3 1.99 
Race        17.47** 
 Non-White 102 20.9 273 27.7 240 31.5  
 Unknown 35 7.2 78 7.9 53 7.0  
Hispanic/Latin
o ethnicity 
41 8.4 116 11.8 108 14.2 9.38** 
Married 264 54.2 508 51.5 424 55.6 3.40 
Comorbid 
depression  
238 48.9 576 58.4 464 60.8 18.40*** 
Comorbid 
psychosis 
20 4.1 39 4.0 48 6.3 5.80 
Comorbid 
substance use  




179 36.8 334 33.8 275 36.0 1.55 
Comorbid 
sleep disorder  
109 22.4 237 24.0 222 29.1 8.85* 
Traumatic 
brain injury  
13  2.7 29 2.9 19 2.5 0.33 
Elixhauser 
score  
0.12 3.60 0.08 3.82 0.33 3.86 5.77 
Mental health 
visits in past 
year  






4.51 8.27 4.93 8.89 5.05 8.75 4.05 














50.18 10.33 60.43 8.57 71.41 7.21 1058.22**
* 
Final PCL score  33.95  8.71 52.08 8.93 69.35 7.84 1594.99**
* 
Note. PCL = PTSD Checklist. *p < .05.  **p < .01. ***p < .001. 
Table 4. Summary of Adjusted Multinomial Regression Results Predicting Trajectory 
Membership 
















   
Characteristic RRR 95% CI RRR 95% CI RRR 95% CI 
Gender (male 
vs. female) 
1.21  [0.90, 1.62] 1.48  [1.08, 
2.02]* 




1.51  [1.15, 
1.98]** 
1.77  [1.33, 
2.35]*** 




1.58  [1.08, 2.30]* 2.07  [1.40, 
3.04]*** 
1.31  [0.98, 1.75] 
Depression 
(yes vs. no) 
1.45  [1.16, 
1.81]** 
1.58  [1.25, 
1.99]*** 




1.02  [0.79, 1.33] 1.28  [0.99, 1.68] 1.25  [1.01, 
1.55]* 
Note. CI = confidence interval; RRR = relative risk ratio. *p < .05 **p < .01 ***p < .001. 
 
 
 
 
